Acquired by SEED
Industries Emergency MedicineHealth CareMedicalMedical DevicePersonal HealthHeadquarters Regions Europe, Middle East, and Africa (EMEA) Founded Date 2003 Founders Matteo Leonardi, Sacha Cerboni Operating Status Active Last Funding Type Series C Legal Name Sensimed AG
Company Type For Profit
Contact Email info@sensimed.ch Phone Number 41 21 621 91 91
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours.
Sensimed is now focused on expanding the knowledge of how this individual data can best be
used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment.
Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.
Transaction Name SENSIMED acquired by SEEDAcquired by SEEDAnnounced Date Dec 12, 2019